by mandarabiopharma_jzpe7a | Aug 17, 2026 | Uncategorized
BOULDER, Colorado, August 17, 2026 – Mandara Biopharma Inc., a privately held U.S.-based biopharmaceutical company focused on novel therapies for central nervous system (CNS) disorders, officially launched their Phase 2/3 clinical trial in Australia for the treatment...
by mandarabiopharma_jzpe7a | Feb 17, 2026 | Uncategorized
BOULDER, Colo., February 17, 2026 – Mandara Biopharma Inc., a privately held U.S.-based biopharmaceutical company focused on novel therapies for central nervous system (CNS) disorders, today announced that it has received approval from the U.S. Food and Drug...
by mandarabiopharma_jzpe7a | Jan 12, 2026 | Uncategorized
BOULDER, Colo., January 12, 2026 – Mandara Biopharma Inc., a privately held U.S.-based biopharmaceutical company focused on novel therapies for central nervous system (CNS) disorders, today announced that it has filed an Investigational New Drug (IND) application with...
